Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with multiple myeloma and are receiving initial treatment to prepare for a stem cell transplant using your own stem cells
- You are willing and able to follow all birth control requirements during the trial
- You are generally able to carry out daily activities with little or no limitation (confirm with trial site)
- Your liver function blood test results are within an acceptable range (confirm with trial site)
- Enough of your stem cells (a specific type called CD34+ cells) have already been successfully collected for transplant
- Your blood counts, including infection-fighting cells and platelets, are at an acceptable level (confirm with trial site)
- Your doctor expects you to live for more than 3 months
- You (or a close family member) have signed a form giving your informed consent to take part
Who may not be able to join:
- Your doctor does not think you would be able to tolerate certain treatments used in this trial, specifically a drug called melphalan or radiation therapy
- You have a known active hepatitis B or hepatitis C infection, or have tested positive for HIV
- You have heart or blood vessel disease that is severe or not well controlled
- You have a serious physical or mental health condition that your doctor feels would make it unsafe or unsuitable for you to participate
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fuling Zhou, Wuhan University
Phone: +86-02767813137
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Complete response rate and above 100 days after transplantation (≥ CR rate)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.